Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archives of Internal Medicine

• Publication date

  2010-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archinternmed.2010.233PMID 20660845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2011cited by this paper
• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2009cited by this paper
• Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

  2008cited by this paper
• Chronic Health Conditions in Adult Survivors of Childhood Cancer

  2008cited by this paper
• Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined.

  2007cited by this paper
• Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

  2007cited by this paper
• Late cardiotoxicity after treatment for Hodgkin lymphoma.

  2007cited by this paper
• Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.

  2007cited by this paper
• Chronic health conditions in adult survivors of childhood cancer.

  2006cited by this paper
• Geographical Patterns and Time Trends of Cancer Incidence and Survival Among Children and Adolescents in Europe Since the 1970s (the ACCIS Project): An Epidemiological Study

  2006cited by this paper
• Caring for survivors of childhood cancers: the size of the problem.

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

  2006influential reference
• Long-term cardiac follow-up in survivors of a malignant bone tumour.

  2006influential reference
• Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS).

  2006cited by this paper
• Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

  2005influential reference
• Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.

  2005cited by this paper
• Cardiac toxicity of high-dose chemotherapy

  2005cited by this paper
• Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and prevention

  2005cited by this paper
• Cardiotoxicity of Cancer Chemotherapy

  2005cited by this paper
• Long‐term cause‐specific mortality among five‐year survivors of childhood cancer

  2004cited by this paper
• Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study.

  2004cited by this paper
• Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

  2004cited by this paper
• Non-invasive evaluation of late cardiac toxicity in childhood cancer survivors.

  2004cited by this paper
• Common Terminology Criteria for Adverse Events v3.0 (CTCAE)

  2003cited by this paper
• Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.

  2003cited by this paper
• Late anthracycline cardiotoxicity after childhood cancer

  2003cited by this paper
• Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children.

  2003influential reference
• Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.

  2002influential reference
• Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

  2002influential reference
• Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

  2002influential reference
• Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries.

  2001cited by this paper
• Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

  2001cited by this paper
• Childhood cancer and the price of cure: studies on late effects of childhood cancer treatment

  2000cited by this paper
• Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.

  2000cited by this paper
• Cardiac Dysfunction and Mortality in HIV-Infected Children: The Prospective P2C2 HIV Multicenter Study

  2000cited by this paper
• Anthracycline-induced cardiotoxicity.

  2000cited by this paper
• Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

  2000cited by this paper
• Cardiotoxicity of Chemotherapeutic Agents

  2000cited by this paper
• Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

  1998cited by this paper
• Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.

  1997cited by this paper
• Anthracycline-Induced Cardiotoxicity

  1996cited by this paper
• Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

  1995cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper
• A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991influential reference

• Electrocardiographic changes and their impact on psychological distress and sleep quality in breast cancer patients during anthracycline-based chemotherapy

  2026cites this paper
• Long-term Subclinical Cardiotoxicity of Modern Cardiotoxic Treatment Protocols in Childhood Cancer Survivors Assessed by Cardiovascular Magnetic Resonance T1 Mapping and Circulatory Biomarkers

  2026cites this paper
• Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring.

  2026cites this paper
• Longitudinal Trajectory of Left Ventricular Systolic Function in Children During Anthracycline‐Based Chemotherapy Assessed by Noninvasive Myocardial Work

  2025cites this paper
• Long-term effects of antitumor treatment of acute lymphoblastic leukemia

  2025cites this paper
• Anthracycline‐Induced Cardiomyopathy After Nephro‐/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment

  2025cites this paper
• The Interplay Between Cardiac Metabolism and Tumor Cell Biology: Metabolic Remodeling

  2025cites this paper
• Redefining Survivorship in Pediatric Oncology: A Fresh Look at a Long-Term Problem.

  2025cites this paper
• QTc intervals at rest and during exercise assessed by group correction formulas in survivors of childhood acute lymphoblastic leukemia.

  2024cites this paper
• Kardiale Spätfolgen einer Krebstherapie und Möglichkeiten der Prävention

  2024cites this paper
• Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity

  2024cites this paper
• How I Treat: long-term survivors of childhood acute leukemia.

  2024cites this paper
• Oxime Linked Doxorubicin Glycoconjugates Improve the Specific Targeting of Glioblastoma in High-Grade Glioma Therapy.

  2024cites this paper
• A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors

  2024cites this paper
• The Role of Diet in the Cardiovascular Health of Childhood Cancer Survivors—A Systematic Review

  2024cites this paper
• Clinical Care for People Who Survive Childhood Cancer: A Review.

  2023cites this paper
• Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity

  2023cites this paper
• Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies

  2023cites this paper
• Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

  2023cites this paper
• Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: a systematic review

  2023cites this paper
• Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors

  2023cites this paper
• A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment

  2023cites this paper
• Significance of active screening for detection of health problems in childhood cancer survivors

  2022cites this paper
• Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France

  2022cites this paper
• All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity

  2022cites this paper
• Consensus-Based Cardiomyopathy Care in Childhood Cancer Survivors

  2022cites this paper
• Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation.

  2022cites this paper
• Sex-Specific Cardiovascular Risks of Cancer and Its Therapies

  2022cites this paper
• Identifying causal relationships of cancer treatment and long-term health effects among 5-year survivors of childhood cancer in Southern Sweden

  2022cites this paper
• Left ventricular function in pediatric all survivors using speckle-tracking echocardiography and its relation to N-terminal brain natriuretic peptide

  2022cites this paper
• Extracellular matrix remodeling in anthracycline-induced cardiotoxicity: What place on the pedestal?

  2022cites this paper
• Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients.

  2022cites this paper
• Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

  2022cites this paper
• Myocardial Deformation Imaging by Speckle Tracking Echocardiography for Assessment of Cardiotoxicity in Children During and After Chemotherapy: A Systematic Review and Meta-analysis.

  2022cites this paper
• Automated Global Longitudinal Strain Assessment in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia

  2022cites this paper
• Prognostic value of matrix metalloproteinases in patients with anthracycline-induced heart failure

  2022cites this paper
• Cardiac function in childhood cancer survivors treated with vincristine: Echocardiographic results from the DCCSS LATER 2 CARD study.

  2022cites this paper
• Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology

  2021cites this paper
• Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity.

  2021cites this paper
• Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice

  2021cites this paper
• Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review

  2021cites this paper
• Modelling adverse drug reactions using induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs)

  2021cites this paper
• Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer

  2021influential citation
• CardioOncology

  2021cites this paper
• Prognostic Factors for Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients Treated with Current Anthracycline Regimens

  2021cites this paper
• Rational, design and preliminary results of a cohort study on breast and colorectal cancer to develop a risk assessment model to predict future cardiovascular events. "Cardio vascular events In Breast and Colorectal cancers (CIBC) study".

  2021cites this paper
• Anthracycline Induced Cardiac Disorders in Childhood Acute Lymphoblastic Leukemia: A Single-Centre, Retrospective, Observational Study

  2021cites this paper
• Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy

  2021cites this paper
• MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review

  2021cites this paper
• Specific Issues of Children and Young Adults in Survivorship Care

  2021cites this paper
• Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study

  2021cites this paper
• Effect of Mineralocorticoid Receptor Antagonists on Secondary Prevention of Cardiomyopathy Progression in Childhood Cancer Survivors

  2021cites this paper
• Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model

  2021cites this paper
• Cardiac Disease in Childhood Cancer Survivors Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review

  2020cites this paper
• Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study (Preprint)

  2020cites this paper
• Treatment of Hepatoblastoma With Drug-eluting Bead Transarterial Chemoembolization in a 13-Month-Old Infant: A Case Report and Review of the Literature

  2020cites this paper
• Cardiotoxicity After Childhood Cancer Treatment

  2020cites this paper
• Genetics of Anthracycline Cardiomyopathy in Cancer Survivors

  2020cites this paper
• Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer.

  2020cites this paper
• Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.

  2020cites this paper
• Age-Related Considerations in Cardio-Oncology

  2020cites this paper
• Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

  2020cites this paper
• Unique needs of childhood cancer survivors during the COVID-19 pandemic

  2020cites this paper
• Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study

  2020cites this paper
• Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors

  2020cites this paper
• Prospective Single Center Cohort Study for Early Diagnosis of Cardiac Dysfunction in Swiss Childhood Cancer Survivors: A Study Protocol

  2020cites this paper
• Onkologische Kardiologie

  2020cites this paper
• Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging

  2020cites this paper
• Cardiac Disease in Childhood Cancer Survivors

  2020cites this paper
• Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study.

  2019cites this paper
• Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers

  2019cites this paper
• A comparison of two models of follow-up care for adult survivors of childhood cancer

  2019cites this paper
• Cranial Irradiation in Childhood Acute Lymphoblastic Leukemia Is Related to Subclinical Left Ventricular Dysfunction and Reduced Large Artery Compliance in Cancer Survivors

  2019cites this paper
• Cytotoxic and apoptosis-inducing effects of Sutherlandia frutescens in neuroblastoma cells

  2019cites this paper
• Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series

  2019cites this paper
• Doxorubicin‐induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy

  2019cites this paper
• Communicating health information and improving coordination with primary care (CHIIP): Rationale and design of a randomized cardiovascular health promotion trial for adult survivors of childhood cancer.

  2019cites this paper
• Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study

  2019cites this paper
• Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.

  2019cites this paper
• Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment

  2019cites this paper
• Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines

  2019cites this paper
• Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell Modeling

  2019cites this paper
• Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy

  2019cites this paper
• Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon.

  2018cites this paper
• Mechanism and Prevention of Cardiomyopathy Due to Chemotherapy

  2018cites this paper
• Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study

  2018cites this paper
• Predicting and Preventing Anthracycline-Related Cardiotoxicity.

  2018cites this paper
• Echocardiographic evolution of left ventricular function in childhood leukemia survivors.

  2018cites this paper
• Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review

  2018cites this paper
• Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity

  2018cites this paper
• Childhood Cancer Survivor Study (CCSS) Concept Title: Pathogenesis of anthracycline-related cardiomyopathy in childhood cancer survivors Working Groups: Genetics (primary); Chronic Diseases (secondary); Epidemiology/ Biostatistics (secondary) Roster of Investigators

  2018cites this paper
• Risk and associated risk factors of hospitalization for specific health problems over time in childhood cancer survivors: a medical record linkage study

  2017cites this paper
• The Effect of Atorvastatin on Vascular Function and Structure in Young Adult Survivors of Childhood Cancer: A Randomized, Placebo-Controlled Pilot Clinical Trial

  2017cites this paper
• Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot

  2017cites this paper
• Is screening for abnormal ECG patterns justified in long‐term follow‐up of childhood cancer survivors treated with anthracyclines?

  2017cites this paper
• The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography.

  2017cites this paper
• Prevention of cardiotoxicity among survivors of childhood cancer

  2017cites this paper
• Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review

  2017cites this paper
• Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

  2017cites this paper
• [Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up].

  2017cites this paper